Certified by Founder
Lodge
hema.to GmbH
start up
Germany
- Munich
- 07/03/2025
- Unknown
- $3,900,060
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
- Industry Software Development
- Website https://www.hema.to/
- LinkedIn https://www.linkedin.com/company/hemato/
Related People
Karsten MiermansFounder
Germany -
Munich, Bavaria
Founder of an AI diagnostic start-up, passionate about improving cytometry and blood cancer diagnostics. I have a background in theoretical biophysics, but I'm a generalist at heart. My fundamental drivers are growth, honesty, efficiency and curiosity. In my spare time, I enjoy reading great works, electronic music and teaching rationality.
Pluvo | $5,000,000 | (Mar 3, 2026)
Flux(US) | $27,000,000 | (Mar 3, 2026)
Multitude Insights | $10,000,000 | (Mar 3, 2026)
Plurio by Elly Analytics | $3,500,000 | (Mar 3, 2026)
Huper Corporation | $1,500,000 | (Mar 3, 2026)
MeltPlan | $10,000,000 | (Mar 3, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)
Procode AI | $4,000,000 | (Mar 3, 2026)
Temple | $54,000,000 | (Mar 3, 2026)
SECONDSENSE | $2,000,000 | (Mar 3, 2026)
Ease Health | $41,000,000 | (Mar 3, 2026)
Smack Technologies Inc. | $32,000,000 | (Mar 3, 2026)